What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary
Int J Rheum Dis
.
2021 Oct;24(10):1331-1333.
doi: 10.1111/1756-185X.14214.
Epub 2021 Sep 14.
Author
Giovanni Iolascon
1
Affiliation
1
University of Campania "Luigi Vanvitelli", Naples, Italy.
PMID:
34523249
PMCID:
PMC9292524
DOI:
10.1111/1756-185X.14214
No abstract available
Keywords:
Cochrane Review summary; belimumab; systemic lupus erythematosus.
Publication types
Comment
MeSH terms
Antibodies, Monoclonal, Humanized*
Humans
Lupus Erythematosus, Systemic*
Substances
Antibodies, Monoclonal, Humanized
belimumab